This lecture provides an overview of the incretin system and its role in human physiology. It then includes data on impairment of this system in type 2 diabetes. The currently available GLP-1 receptor agonists and DPP-4 inhibitors are then described and data provided on studies showing their effect in patients with type 2 diabetes.